This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Mevalonate pathway
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | <StructureSection load='' size='350' side='right' scene='HMG-CoA_Reductase/1dq8_starting_scene/1' caption='Crystal Structure of HMG-CoA, (PDB code [[1dq8]])'> | ||
Production of mevalonate is the rate-limiting and irreversible step in cholesterol synthesis and is the site of action for statins. | Production of mevalonate is the rate-limiting and irreversible step in cholesterol synthesis and is the site of action for statins. | ||
| Line 38: | Line 39: | ||
Mevalonate is finally converted to isopentenyl pyrophosphate. | Mevalonate is finally converted to isopentenyl pyrophosphate. | ||
| + | |||
| + | </StructureSection> | ||
| + | == References == | ||
| + | <references/> | ||
Revision as of 11:06, 3 October 2022
| |||||||||||
